BiSiChem's new drug candidate pipeline is the high priority projects

that global pharmaceutical companies are looking for

Innovative new drug development (first-in-class)

Global pharmaceutical company
  • Small molecule Immuno-oncology Inhibitor 

  • Targeted cancer drug

BiSiChem’s Innovative Cancer Drug Candidate
  • High selective RAF family inhibitor

  • Good physicochemical properties & lower toxicity

  • Proved TGI efficacy against Melanoma and Colon

  • Clinical candidate as innovative oncology product